Comments
Loading...

Cabaletta Bio

CABANASDAQ
Logo brought to you by Benzinga Data
$2.74
0.3112.76%
At close: -
$2.70
-0.04-1.46%
After Hours: Jan 17, 7:28 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$50.00
Lowest Price Target1
$6.00
Consensus Price Target1
$24.00

Cabaletta Bio (NASDAQ:CABA) Stock, Analyst Ratings, Price Targets, Forecasts

Quote.Descriptions.analyst-ratings.

Analyst Trends and Forecast
1
Oct 24
3
Nov 24
1
Dec 24
1
Jan
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.5
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Evercore ISI Group
Wells Fargo
UBS
Cantor Fitzgerald

1calculated from analyst ratings

Analyst Ratings for Cabaletta Bio

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Cabaletta Bio (CABA) stock?

A

The latest price target for Cabaletta Bio (NASDAQ:CABA) was reported by HC Wainwright & Co. on January 17, 2025. The analyst firm set a price target for $25.00 expecting CABA to rise to within 12 months (a possible 825.93% upside). 22 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Cabaletta Bio (CABA)?

A

The latest analyst rating for Cabaletta Bio (NASDAQ:CABA) was provided by HC Wainwright & Co., and Cabaletta Bio reiterated their buy rating.

Q

When was the last upgrade for Cabaletta Bio (CABA)?

A

The last upgrade for Cabaletta Bio Inc happened on January 27, 2023 when Morgan Stanley raised their price target to $16. Morgan Stanley previously had an equal-weight for Cabaletta Bio Inc.

Q

When was the last downgrade for Cabaletta Bio (CABA)?

A

The last downgrade for Cabaletta Bio Inc happened on December 20, 2024 when Evercore ISI Group changed their price target from $15 to $6 for Cabaletta Bio Inc.

Q

When is the next analyst rating going to be posted or updated for Cabaletta Bio (CABA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cabaletta Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cabaletta Bio was filed on January 17, 2025 so you should expect the next rating to be made available sometime around January 17, 2026.

Q

Is the Analyst Rating Cabaletta Bio (CABA) correct?

A

While ratings are subjective and will change, the latest Cabaletta Bio (CABA) rating was a reiterated with a price target of $25.00 to $25.00. The current price Cabaletta Bio (CABA) is trading at is $2.70, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch